Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVCT | IPHA | ACTU | ||
| Company | Nuvectis Pharma Inc | Innate Pharma S.A. ADR | Actuate Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 6.78 | 1.8800 | 7.48 | ||
| High | 6.84 | 1.9600 | 7.64 | ||
| Low | 6.60 | 1.8800 | 7.30 | ||
| Latest | 6.71 | 1.8900 | 7.35 | ||
| Change | -0.03 | -0.0200 | unch | ||
| % Change | -0.52% | -1.05% | unch | ||
| Volume | 104,200 | 12,600 | 57,100 | ||
| 20-Day Average Volume | 85,805 | 564,915 | 60,040 | ||
| Previous Close | 6.74 | 1.9100 | 7.35 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 6.11 | 1.8943 | 6.51 | ||
| 20-Day Raw Stochastic | 89.92% | 23.02% | 79.93% | ||
| 20-Day Relative Strength | 58.29 | 47.89 | 56.52 | ||
| Weighted Alpha | +16.97 | -11.18 | -19.30 | ||
| Today's Opinion | 40% Sell | 80% Sell | 40% Sell | ||
| Previous Opinion | 40% Sell | 80% Sell | 40% Sell | ||
| Last Month's Opinion | 100% Sell | 24% Sell | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.53% since 11/28/25 | -3.08% since 11/28/25 | -3.67% since 11/28/25 | ||
| Low | 5.77 on 12/02/25 | 1.8500 on 12/03/25 | 7.05 on 12/01/25 | ||
| High | 6.84 on 12/05/25 | 2.0100 on 12/01/25 | 7.64 on 12/05/25 | ||
| 1-Month | |||||
| %Chg | +18.76% since 11/05/25 | +3.85% since 11/05/25 | +13.78% since 11/05/25 | ||
| Low | 5.55 on 11/07/25 | 1.7300 on 11/18/25 | 5.61 on 11/20/25 | ||
| High | 6.84 on 12/05/25 | 2.4250 on 11/10/25 | 7.79 on 11/28/25 | ||
| 3-Month | |||||
| %Chg | +0.45% since 09/05/25 | -7.80% since 09/05/25 | -10.80% since 09/05/25 | ||
| Low | 5.55 on 11/07/25 | 1.7300 on 11/18/25 | 5.61 on 11/20/25 | ||
| High | 7.00 on 10/29/25 | 2.4250 on 11/10/25 | 8.55 on 09/09/25 | ||
| 6-Month | |||||
| %Chg | -25.20% since 06/05/25 | -12.09% since 06/05/25 | -19.14% since 06/05/25 | ||
| Low | 5.55 on 11/07/25 | 1.7000 on 07/14/25 | 5.47 on 07/21/25 | ||
| High | 9.30 on 06/11/25 | 2.6300 on 07/30/25 | 9.35 on 06/09/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 172,773 | 176,073 | 170,836 | ||
| Shares Outstanding, K | 25,615 | 92,185 | 23,243 | ||
| Annual Sales | 0 | 21,770,000 | 0 | ||
| Annual Net Income | -19,000,000 | -53,530,000 | -27,290,000 | ||
| Last Quarter Sales | 0 | N/A | 0 | ||
| Last Quarter Net Income | -7,460,000 | N/A | -5,410,000 | ||
| 60-Month Beta | -0.27 | -0.08 | -0.34 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.44 on 11/04/25 | N/A | -0.25 on 11/13/25 | ||
| Latest Earnings Date | 11/04/25 | 11/13/25 | 11/12/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||